Literature DB >> 8615422

Use of methods from chaos theory to quantify a fundamental dysfunction in the behavioral organization of schizophrenic patients.

M P Paulus1, M A Geyer, D L Braff.   

Abstract

OBJECTIVE: This study aimed to quantify the complexity of behavioral sequences of patients with schizophrenia and comparison subjects by using methods from nonlinear dynamical systems theory.
METHOD: A simple choice task consisting of predicting 500 random right or left appearances of a stimulus was used to obtain binary response sequences in 22 patients with schizophrenia and 16 comparison subjects. Dynamical entropy was measured and the fluctuation spectrum of local subsequence entropies calculated to quantify the degree of interdependency between consecutive responses of patients and comparison subjects.
RESULTS: The response sequences generated by the schizophrenic patients exhibited a higher degree of interdependency than those of comparison subjects. Moreover, schizophrenic patients exhibited significantly less consistency in their response selection and ordering, characterized by a greater contribution of both highly perseverative and highly unpredictable subsequences of responses within a test session.
CONCLUSIONS: The result of the biological abnormality underlying schizophrenia may not be a simple increase or decrease of neuropsychological or neurobiological functions. Instead, the observed abnormalities in behavioral patterns reflect a quantifiable dysregulation and disorganization of these functions.

Entities:  

Mesh:

Year:  1996        PMID: 8615422     DOI: 10.1176/ajp.153.5.714

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

1.  Brief report: attention differences in Asperger syndrome.

Authors:  Amy M Schatz; Amy K Weimer; Doris A Trauner
Journal:  J Autism Dev Disord       Date:  2002-08

2.  Reduced behavioral and neural activation in stimulant users to different error rates during decision making.

Authors:  Martin P Paulus; Kathryn L Lovero; Marc Wittmann; David S Leland
Journal:  Biol Psychiatry       Date:  2007-10-22       Impact factor: 13.382

3.  Quantitative characterization of animal behavior following blast exposure.

Authors:  Paul Ernest Rapp
Journal:  Cogn Neurodyn       Date:  2007-10-16       Impact factor: 5.082

4.  Neural complexity as a potential translational biomarker for psychosis.

Authors:  Brandon Hager; Albert C Yang; Roscoe Brady; Shashwath Meda; Brett Clementz; Godfrey D Pearlson; John A Sweeney; Carol Tamminga; Matcheri Keshavan
Journal:  J Affect Disord       Date:  2016-10-26       Impact factor: 4.839

5.  Power spectrum scale invariance identifies prefrontal dysregulation in paranoid schizophrenia.

Authors:  Anca R Radulescu; Denis Rubin; Helmut H Strey; Lilianne R Mujica-Parodi
Journal:  Hum Brain Mapp       Date:  2011-05-12       Impact factor: 5.038

Review 6.  Is active psychosis neurotoxic?

Authors:  T H McGlashan
Journal:  Schizophr Bull       Date:  2006-08-16       Impact factor: 9.306

7.  Optimizing vs. matching: response strategy in a probabilistic learning task is associated with negative symptoms of schizophrenia.

Authors:  Zuzana Kasanova; James A Waltz; Gregory P Strauss; Michael J Frank; James M Gold
Journal:  Schizophr Res       Date:  2011-01-15       Impact factor: 4.939

Review 8.  Animal to human translational paradigms relevant for approach avoidance conflict decision making.

Authors:  Namik Kirlic; Jared Young; Robin L Aupperle
Journal:  Behav Res Ther       Date:  2017-04-24

9.  Blunted Frontostriatal Blood Oxygen Level-Dependent Signals Predict Stimulant and Marijuana Use.

Authors:  Melanie A Blair; Jennifer L Stewart; April C May; Martina Reske; Susan F Tapert; Martin P Paulus
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-03-21

10.  Non-Linear Dynamic Analysis of Inter-Word Time Intervals in Psychotic Speech.

Authors:  Doron Todder; Sofia Avissar; Gabriel Schreiber
Journal:  IEEE J Transl Eng Health Med       Date:  2013-07-12       Impact factor: 3.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.